The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Phage therapy: An alternative to antibiotics in the age of multi-drug resistance
Open accessAbstract
The practice of phage therapy, which uses bacterial viruses (phages) to treat bacterial infections, has been around for almost a century. The universal decline in the effectiveness of antibiotics has generated renewed interest in revisiting this practice. Conventionally, phage therapy relies on the use of naturally-occurring phages to infect and lyse bacteria at the site of infection. Biotechnological advances have further expanded the repertoire of potential phage therapeutics to include novel strategies using bioengineered phages and purified phage lytic proteins. Current research on the use of phages and their lytic proteins, specifically against multidrug-resistant bacterial infections, suggests phage therapy has the potential to be used as either an alternative or a supplement to antibiotic treatments. Antibacterial therapies, whether phage- or antibiotic-based, each have relative advantages and disadvantages; accordingly, many considerations must be taken into account when designing novel therapeutic approaches for preventing and treating bacterial infections. Although much is still unknown about the interactions between phage, bacteria, and human host, the time to take phage therapy seriously seems to be rapidly approaching.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Antibiotic resistance-the need for global solutions
Laxminarayan, R., Duse, A., Wattal, C., Zaidi, A. K. M., Wertheim, H. F. L., Sumpradit, N., Vlieghe, E., Hara, G. L., Gould, I. M., Goossens, H., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70318-9 · Cited by 4,439
Marine viruses — major players in the global ecosystem
Suttle, C. A. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1750 · Cited by 3,157
Bacteriophage resistance mechanisms
Labrie, S. J., Samson, J. E., & Moineau, S. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2315 · Cited by 2,397
Ecology of prokaryotic viruses
Weinbauer, M. G. (2004) · FEMS Microbiology Reviews · doi:10.1016/j.femsre.2003.08.001 · Cited by 1,771
Sulakvelidze, A., Alavidze, Z., & Morris, J. G. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.649-659.2001 · Cited by 1,566
Viruses in the faecal microbiota of monozygotic twins and their mothers
Reyes, A., Haynes, M., Hanson, N., Angly, F. E., Heath, A. C., Rohwer, F., & Gordon, J. I. (2010) · Nature · doi:10.1038/nature09199 · Cited by 1,194
Antibiotic resistance genes in water environment
Zhang, X.-X., Zhang, T., & Fang, H. H. P. (2009) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-008-1829-z · Cited by 998
The human gut virome: inter-individual variation and dynamic response to diet
Minot, S., Sinha, R., Chen, J., Li, H., Keilbaugh, S. A., Wu, G. D., Lewis, J. D., & Bushman, F. D. (2011) · Genome Research · doi:10.1101/gr.122705.111 · Cited by 935
Phage Cocktails and the Future of Phage Therapy
Chan, B. K., Abedon, S. T., & Loc-Carrillo, C. (2013) · Future Microbiology · doi:10.2217/fmb.13.47 · Cited by 914
Koskella, B., & Brockhurst, M. A. (2014) · FEMS Microbiology Reviews · doi:10.1111/1574-6976.12072 · Cited by 890
Self-citationWright, A., Hawkins, C. H., Änggård, E. E., & Harper, D. R. (2009) · Clinical Otolaryngology · doi:10.1111/j.1749-4486.2009.01973.x · Cited by 864
Costerton, J. (1999) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(99)00018-7 · Cited by 727
Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa
Chan, B. K., Sistrom, M., Wertz, J. E., Kortright, K. E., Narayan, D., & Turner, P. E. (2016) · Scientific Reports · doi:10.1038/srep26717 · Cited by 715
Vital signs: carbapenem-resistant Enterobacteriaceae.
(2013) · PubMed Central · Cited by 604
Wittebole, X., De Roock, S., & Opal, S. M. (2014) · Virulence · doi:10.4161/viru.25991 · Cited by 599
Human Volunteers Receiving Escherichia coli Phage T4 Orally: a Safety Test of Phage Therapy
Bruttin, A., & Brüssow, H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.2874-2878.2005 · Cited by 563
Hicks, L. A., Bartoces, M. G., Roberts, R. M., Suda, K. J., Hunkler, R. J., Taylor, T. H., & Schrag, S. J. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ076 · Cited by 559
Antibiotic treatment expands the resistance reservoir and ecological network of the phage metagenome
Modi, S. R., Lee, H. H., Spina, C. S., & Collins, J. J. (2013) · Nature · doi:10.1038/nature12212 · Cited by 542
Bacteriophages and their genomes
Hatfull, G. F., & Hendrix, R. W. (2011) · Current Opinion in Virology · doi:10.1016/j.coviro.2011.06.009 · Cited by 541
Antibiotics in early life and obesity
Cox, L. M., & Blaser, M. J. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.210 · Cited by 541
Emergency Department Visits for Antibiotic‐Associated Adverse Events
Shehab, N., Patel, P. R., Srinivasan, A., & Budnitz, D. S. (2008) · Clinical Infectious Diseases · doi:10.1086/591126 · Cited by 535
Sarker, S. A., Sultana, S., Reuteler, G., Moine, D., Descombes, P., Charton, F., Bourdin, G., McCallin, S., Ngom-Bru, C., Neville, T., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2015.12.023 · Cited by 533
Merabishvili, M., Pirnay, J.-P., Verbeken, G., Chanishvili, N., Tediashvili, M., Lashkhi, N., Glonti, T., Krylov, V., Mast, J., Van Parys, L., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004944 · Cited by 511
The microbiome: a key regulator of stress and neuroinflammation
Rea, K., Dinan, T. G., & Cryan, J. F. (2016) · Neurobiology of Stress · doi:10.1016/j.ynstr.2016.03.001 · Cited by 508
Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria
Yosef, I., Manor, M., Kiro, R., & Qimron, U. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1500107112 · Cited by 483
Bacteriophages as potential new therapeutics to replace or supplement antibiotics
Kutateladze, M., & Adamia, R. (2010) · Trends in Biotechnology · doi:10.1016/j.tibtech.2010.08.001 · Cited by 483
Biswas, B., Adhya, S., Washart, P., Paul, B., Trostel, A. N., Powell, B., Carlton, R., & Merril, C. R. (2002) · Infection and Immunity · doi:10.1128/iai.70.1.204-210.2002 · Cited by 467
Engineered Endolysin-Based “Artilysins” To Combat Multidrug-Resistant Gram-Negative Pathogens
Briers, Y., Walmagh, M., Van Puyenbroeck, V., Cornelissen, A., Cenens, W., Aertsen, A., Oliveira, H., Azeredo, J., Verween, G., Pirnay, J.-P., et al. (2014) · mBio · doi:10.1128/mbio.01379-14 · Cited by 421
Bacteriophage Receptors, Mechanisms of Phage Adsorption and Penetration into Host Cell
RAKHUBA, D. V., KOLOMIETS, E. I., DEY, E. S., & NOVIK, G. I. (2010) · Polish Journal of Microbiology · doi:10.33073/pjm-2010-023 · Cited by 419
Understanding Bacteriophage Specificity in Natural Microbial Communities
Koskella, B., & Meaden, S. (2013) · Viruses · doi:10.3390/v5030806 · Cited by 410
Self-citationPhage Therapy—History from Twort and d'Herelle Through Soviet Experience to Current Approaches
Chanishvili, N. (2012) · Advances in Virus Research · doi:10.1016/b978-0-12-394438-2.00001-3 · Cited by 407
Bacteriophage-mediated spread of bacterial virulence genes
Penadés, J. R., Chen, J., Quiles-Puchalt, N., Carpena, N., & Novick, R. P. (2015) · Current Opinion in Microbiology · doi:10.1016/j.mib.2014.11.019 · Cited by 367
Biofilm susceptibility to bacteriophage attack: the role of phage-borne polysaccharide depolymerase
Hughes, K. A., Sutherland, I. W., & Jones, M. V. (1998) · Microbiology · doi:10.1099/00221287-144-11-3039 · Cited by 360
Antibiotic Resistance Genes in the Bacteriophage DNA Fraction of Environmental Samples
Colomer-Lluch, M., Jofre, J., & Muniesa, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017549 · Cited by 353
Preventing biofilms of clinically relevant organisms using bacteriophage
Donlan, R. M. (2009) · Trends in Microbiology · doi:10.1016/j.tim.2008.11.002 · Cited by 345
Luepke, K. H., Suda, K. J., Boucher, H., Russo, R. L., Bonney, M. W., Hunt, T. D., & Mohr, J. F. (2017) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1868 · Cited by 344
Phage therapy: past history and future prospects.
Carlton, R. M. (1999) · PubMed · Cited by 342
Phage Therapy in the Food Industry
Endersen, L., O'Mahony, J., Hill, C., Ross, R. P., McAuliffe, O., & Coffey, A. (2014) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-030713-092415 · Cited by 338
Mammalian Host-Versus-Phage immune response determines phage fate in vivo
Hodyra-Stefaniak, K., Miernikiewicz, P., Drapała, J., Drab, M., Jończyk-Matysiak, E., Lecion, D., Kaźmierczak, Z., Beta, W., Majewska, J., Harhala, M., et al. (2015) · Scientific Reports · doi:10.1038/srep14802 · Cited by 302
THE GROWTH OF BACTERIOPHAGE AND LYSIS OF THE HOST
Delbrück, M. (1940) · Journal of General Physiology · doi:10.1085/jgp.23.5.643 · Cited by 300
Manipulating Bacterial Communities by in situ Microbiome Engineering
Sheth, R. U., Cabral, V., Chen, S. P., & Wang, H. H. (2016) · Trends in Genetics · doi:10.1016/j.tig.2016.01.005 · Cited by 290
Lood, R., Winer, B. Y., Pelzek, A. J., Diez-Martinez, R., Thandar, M., Euler, C. W., Schuch, R., & Fischetti, V. A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04641-14 · Cited by 272
McCallin, S., Alam Sarker, S., Barretto, C., Sultana, S., Berger, B., Huq, S., Krause, L., Bibiloni, R., Schmitt, B., Reuteler, G., et al. (2013) · Virology · doi:10.1016/j.virol.2013.05.022 · Cited by 265
Phage therapy experience at the Eliava Institute
Kutateladze, M., & Adamia, R. (2008) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2008.06.023 · Cited by 258
Antibiotic susceptibility assay for Staphylococcus aureus in biofilms developed in vitro
Amorena, B., Gracia, E., Monzón, M., Leiva, J., Oteiza, C., Pérez, M., Alabart, J.-L., & Hernández-Yago, J. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/44.1.43 · Cited by 247
Antimicrobial bacteriophage-derived proteins and therapeutic applications
Roach, D. R., & Donovan, D. M. (2015) · Bacteriophage · doi:10.1080/21597081.2015.1062590 · Cited by 245
Nale, J. Y., Spencer, J., Hargreaves, K. R., Buckley, A. M., Trzepiński, P., Douce, G. R., & Clokie, M. R. J. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01774-15 · Cited by 243
Diversification of Escherichia coli genomes: are bacteriophages the major contributors?
Ohnishi, M., Kurokawa, K., & Hayashi, T. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(01)02173-4 · Cited by 240
Górski, A., Ważna, E., DÄ browska, B.-W., DÄ browska, K., ÅwitaÅa-JeleÅ, K., & MiÄdzybrodzki, R. (2006) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2006.00044.x · Cited by 227
Bacteriophage applications: where are we now?
Monk, A. B., Rees, C. D., Barrow, P., Hagens, S., & Harper, D. R. (2010) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.2010.02916.x · Cited by 222
Bacteriophage treatment of intransigent diabetic toe ulcers: a case series
Fish, R., Kutter, E., Wheat, G., Blasdel, B., Kutateladze, M., & Kuhl, S. (2016) · Journal of Wound Care · doi:10.12968/jowc.2016.25.7.s27 · Cited by 222
Treatment of experimental infections of mice with bacteriophages
SOOTHILL, J. S. (1992) · Journal of Medical Microbiology · doi:10.1099/00222615-37-4-258 · Cited by 220
Prenatal and post‐natal exposure to antibiotics and risk of asthma in childhood
Metsälä, J., Lundqvist, A., Virta, L. J., Kaila, M., Gissler, M., & Virtanen, S. M. (2015) · Clinical & Experimental Allergy · doi:10.1111/cea.12356 · Cited by 219
Gilmer, D. B., Schmitz, J. E., Euler, C. W., & Fischetti, V. A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02526-12 · Cited by 216
Watanabe, R., Matsumoto, T., Sano, G., Ishii, Y., Tateda, K., Sumiyama, Y., Uchiyama, J., Sakurai, S., Matsuzaki, S., Imai, S., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00635-06 · Cited by 206
Bacteriophage Therapy of Bacterial Infections: An Update of our Institute’s Experience
Weber-Dąbrowska, B., Mulczyk, M., & Górski, A. (2001) · Inflammation · doi:10.1007/978-94-015-9702-9_15 · Cited by 199
Antimicrobial Resistance and Aging: Beginning of the End of the Antibiotic Era?
Yoshikawa, T. T. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.50.7s.2.x · Cited by 197
Schuch, R., Lee, H. M., Schneider, B. C., Sauve, K. L., Law, C., Khan, B. K., Rotolo, J. A., Horiuchi, Y., Couto, D. E., Raz, A., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit637 · Cited by 196
Calero-Cáceres, W., & Muniesa, M. (2016) · Water Research · doi:10.1016/j.watres.2016.03.006 · Cited by 195
Regeimbal, J. M., Jacobs, A. C., Corey, B. W., Henry, M. S., Thompson, M. G., Pavlicek, R. L., Quinones, J., Hannah, R. M., Ghebremedhin, M., Crane, N. J., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02877-15 · Cited by 187
Experimental Bacteriophage Protection against Staphylococcus aureus Abscesses in a Rabbit Model
Wills, Q. F., Kerrigan, C., & Soothill, J. S. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.1220-1221.2005 · Cited by 180
Oliveira, H., Boas, D. V., Mesnage, S., Kluskens, L., Lavigne, R., Sillankorva, S., Secundo, F., & Azeredo, J. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00208 · Cited by 164
Antibiotic Adverse Reactions and Drug Interactions
Granowitz, E. V., & Brown, R. B. (2008) · Critical Care Clinics · doi:10.1016/j.ccc.2007.12.011 · Cited by 160
Galtier, M., Sordi, L. D., Maura, D., Arachchi, H., Volant, S., Dillies, M., & Debarbieux, L. (2016) · Environmental Microbiology · doi:10.1111/1462-2920.13284 · Cited by 157
Antibiotic Resistance Genes in the Bacteriophage DNA Fraction of Human Fecal Samples
Quirós, P., Colomer-Lluch, M., Martínez‐Castillo, A., Miró, E., Argente, M., Jofre, J. T., Navarro, F., & Muniesa, M. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01684-13 · Cited by 147
Schmelcher, M., Shen, Y., Nelson, D. C., Eugster, M. R., Eichenseher, F., Hanke, D. C., Loessner, M. J., Dong, S., Pritchard, D. G., Lee, J. C., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku552 · Cited by 146
Pouillot, F., Chomton, M., Blois, H., Courroux, C., Noelig, J., Bidet, P., Bingen, É., & Bonacorsi, S. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06330-11 · Cited by 145
Dynamic interactions of biofilms of mucoid Pseudomonas aeruginosa with tobramycin and piperacillin
Anwar, H., Strap, J. L., Chen, K., & Costerton, J. W. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.6.1208 · Cited by 132
Jun, J. W., Shin, T. H., Kim, J. H., Shin, S. P., Han, J. E., Heo, G. J., Zoysa, M. D., Shin, G. W., Chai, J. Y., & Park, S. C. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu059 · Cited by 126
Díez‐Martínez, R., de Paz, H. D., García‐Fernández, E., Bustamante, N., Euler, C. W., Fischetti, V. A., Menéndez, M., & García, P. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv038 · Cited by 121
Wang, J., Hu, B., Xu, M., Yan, Q., Liu, S., Zhu, X., Sun, Z., Reed, E., Ding, L., Gong, J., et al. (2006) · International Journal of Molecular Medicine · doi:10.3892/ijmm.17.2.309 · Cited by 121
Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia*
Witzenrath, M., Schmeck, B., Doehn, J. M., et al. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819586a6 · Cited by 120
Biofilm control with natural and genetically-modified phages
Motlagh, A. M., Bhattacharjee, A. S., & Goel, R. K. (2016) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-016-2009-4 · Cited by 100
Singh, P. K., Donovan, D. M., & Kumar, A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00126-14 · Cited by 99
Pincus, N. B., Reckhow, J. D., Saleem, D., Jammeh, M. L., Datta, S. K., & Myles, I. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124280 · Cited by 97
Bacteriophage infections of microbiota can lead to leaky gut in an experimental rodent model
Tetz, G. V., & Tetz, V. (2016) · Gut Pathogens · doi:10.1186/s13099-016-0109-1 · Cited by 96
Mikkelsen, S. U., Allin, K. H., & Knop, F. K. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12637 · Cited by 94
Ecology of Anti-Biofilm Agents I: Antibiotics versus Bacteriophages
Abedon, S. T. (2015) · Pharmaceuticals · doi:10.3390/ph8030525 · Cited by 90
Bourdin, G., Navarro, A., Sarker, S. A., Pittet, A. C., Qadri, F., Sultana, S., Cravioto, A., Talukder, K. A., Reuteler, G., & Brüssow, H. (2014) · Microbial Biotechnology · doi:10.1111/1751-7915.12113 · Cited by 87
Mai, V., Ukhanova, M., Reinhard, M. K., Li, M., & Sulakvelidze, A. (2015) · Bacteriophage · doi:10.1080/21597081.2015.1088124 · Cited by 87
Wang, J., Hu, B., Xu, M., Yan, Q., Liu, S., Zhu, X., Sun, Z., Tao, D., Ding, L., Reed, E., et al. (2006) · PubMed · Cited by 81
Yang, H., Zhang, Y., Yu, J., Huang, Y., Zhang, X., & Wei, H. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01793-13 · Cited by 79
Koskella, B. (2014) · The American Naturalist · doi:10.1086/676888 · Cited by 77
Self-citationA bacteriophage endolysin that eliminates intracellular streptococci
Shen, Y., Barros, M., Vennemann, T., Gallagher, D. T., Yin, Y., Linden, S. B., Heselpoth, R. D., Spencer, D. J., Donovan, D. M., Moult, J., et al. (2016) · eLife · doi:10.7554/elife.13152 · Cited by 75
Cryptic prophages as targets for drug development
Wang, X., & Wood, T. K. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.06.001 · Cited by 74
Niu, Y. D., Johnson, R. P., Xu, Y., McAllister, T. A., Sharma, R., Louie, M., & Stanford, K. (2009) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2009.04231.x · Cited by 72
Wittekind, M. G., & Schuch, R. (2016) · Current Opinion in Microbiology · doi:10.1016/j.mib.2016.05.006 · Cited by 66
Observation of inflammatory responses in mice orally fed with bacteriophage T7
Park, K., Cha, K., & Myung, H. (2014) · Journal of Applied Microbiology · doi:10.1111/jam.12565 · Cited by 64
Using a Novel Lysin To Help Control Clostridium difficile Infections
Wang, Q., Euler, C. W., Delauné, A., & Fischetti, V. A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01357-15 · Cited by 57
The first phage electron micrographs
Ackermann, H.-W., & Ackermann, H.-W. (2011) · Bacteriophage · doi:10.4161/bact.1.4.17280 · Cited by 56
Preliminary survey of local bacteriophages with lytic activity against multi‐drug resistant bacteria
Latz, S., Wahida, A., Arif, A., Häfner, H., Hoß, M., Ritter, K., & Horz, H. (2016) · Journal of Basic Microbiology · doi:10.1002/jobm.201600108 · Cited by 46
Chopra, S., Harjai, K., & Chhibber, S. (2016) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2016.08.003 · Cited by 45
Rouveix, B. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(02)00354-0 · Cited by 42
Hong, Y., Thimmapuram, J., Zhang, J., Collings, C. K., Bhide, K. P., Schmidt, K., & Ebner, P. (2016) · Bacteriophage · doi:10.1080/21597081.2016.1211066 · Cited by 40
The Janus-Face of Bacteriophages across Human Body Habitats
Wahida, A., Ritter, K., & Horz, H. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005634 · Cited by 29
Keary, R., Sanz‐Gaitero, M., van Raaij, M. J., Mahony, J. O., Fenton, M., McAuliffe, O. E., Hill, C., Ross, R. P., & Coffey, A. (2016) · Current Protein and Peptide Science · doi:10.2174/1389203716666151102105515 · Cited by 25
Cited by
Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review
Mulani, M. S., Kamble, E. E., Kumkar, S. N., Tawre, M. S., & Pardesi, K. R. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00539 · Cited by 1,644
Antibiotic resistance in microbes: History, mechanisms, therapeutic strategies and future prospects
Uddin, T. M., Chakraborty, A. J., Khusro, A., Zidan, B. R. M., Mitra, S., Emran, T. B., Dhama, K., Ripon, M. K. H., Gajdács, M., Sahibzada, M. U. K., et al. (2021) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2021.10.020 · Cited by 1,311
Muteeb, G., Rehman, M. T., Shahwan, M., & Aatif, M. (2023) · Pharmaceuticals · doi:10.3390/ph16111615 · Cited by 1,215
Phage Therapy in the Postantibiotic Era
Gordillo Altamirano, F. L., & Barr, J. J. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00066-18 · Cited by 998
Prevalence and Therapies of Antibiotic-Resistance in Staphylococcus aureus
Guo, Y., Song, G., Sun, M., Wang, J., & Wang, Y. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00107 · Cited by 870
Metadata
- Authors
- Lin, D. M., Koskella, B., & Lin, H. C.
- Venue
- World Journal of Gastrointestinal Pharmacology and Therapeutics
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2017
- Volume
- 8
- Issue
- 3
- Pages
- 162
- ISSN
- 2150-5349 (ISSN-L)
- OpenAlex
- W2741628575
- Cited by
- 1,135
- References
- 97
- FWCI
- 44.29
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.